Advanced NanoTherapies, Inc. (ANT), a clinical-stage medtech company dedicated to improving outcomes for patients with coronary and peripheral artery dis...
NunaBio, a next-generation DNA manufacturing company, has secured £6.5 million in funding to scale-up its proprietary DNA platform and accelerate i...
New company (“NewCo”) co-founded by Nxera with a syndicate of leading healthcare and life sciences-focused investment firms. In return for...
- Initiation of Phase 3 IMPACT DUCHENNE placebo-controlled, randomized, double-blind trial as part of Solid’s integrated, multi-trial development p...
Eli Lilly and Company has announced an additional US$4.5 billion investment into its Indiana manufacturing network, deepening one of the mo...
Investment Strengthens American Manufacturing, Supply Chain Resilience and Next-Generation Technology Amgen announced plans to invest an additional $300...
Transaction Adds Dual BBB Delivery Strategies, Supports Alzheimer's Programs, Combination Therapies, 505(b)(2) Pathways, and CNS Countermeasure Applicati...
FreeMind Investments (FMI), a venture capital fund launched in partnership between FreeMind Group and Daewoong Pharmaceutical Co., Ltd., announced its in...
Deal builds upon UCB’s position as a leader in immunology innovation and expands capabilities in next-generation biologics with potential for i...
TrialClinIQ, an AI-powered clinical trial recruitment platform based in Houston, Texas advancing health equity, announced a $150K pre-seed investment fro...
PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on i...
Marks AbbVie's largest-ever capital investment in a single campus since its inception Investment demonstrates continued progress a...
10x Science, which builds frontier AI for molecular-level protein characterization across the life sciences, today announced the closing of its $4.8M seed ...
Marks the second major investment at the Slovenská Ľupča site in recent years Follows the group’s strategy to strengthen leading ...
© 2026 Biopharma Boardroom. All Rights Reserved.
